Position
Fidelity in Phathom Pharmaceuticals, Inc.
Back to the book · All holders of PHAT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.83K$11.11 → $10.85
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 7.18K | $119.1K | — | — | — | 0.0% |
| Q1 2026 | 7.03K | $78K | $11.11 | −$38.5K | −$2.59K | 0.0% |
| Q2 2026 | 8.23K | $89.3K | $10.85 | −$1.83K | $13.1K | 0.0% |